Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

Gastric cancer, also known as stomach cancer, is a type of cancer that starts in the stomach lining. Detecting the disease early can improve outcomes, but current methods are often invasive. A new ...

Several risk factors contribute to the development of gastric cancer, ranging from bacterial infection from Helicobacter ...

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made “exciting,” patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver ...

Clinical trials with participating cancer patients are estimated to begin in 2027. "This is exciting because we now have all the critical pieces for getting an effective bacterial treatment for ...

Expected to begin in 2027, the trials will involve human patients, and the researchers are working to obtain the necessary ...